Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05310643
Title Nivolumab and Ipilimumab in Patients With dMMR and/or MSI Metastatic Colorectal Cancer Resistant to Anti-PD1 Monotherapy (NIPIRESCUE)
Acronym NIPIRESCUE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GERCOR - Multidisciplinary Oncology Cooperative Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Jean Minjoz NOT_YET_RECRUITING Besançon France Details
CHRU Lille RECRUITING Lille France Details
Centre Léon Bérard NOT_YET_RECRUITING Lyon France Details
ICM Val d'Aurelle NOT_YET_RECRUITING Montpellier France Details
Hôpital Saint Antoine RECRUITING Paris France Details
CHU Poitiers NOT_YET_RECRUITING Poitiers France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field